Clinical Trial Update: Ablative Radioembolization of Renal Cell Carcinoma Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ablative radioembolization for renal cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Derek W. Cool | Conditions: Renal Cell Carcinoma (RCC), Radioembolization | Phase 2 | Status: RECRUITING